Published in Obstet Gynecol on March 01, 2010
Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014. MMWR Recomm Rep (2014) 2.40
Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception. Contraception (2012) 1.62
Ectopic pregnancy rates in the Medicaid population. Am J Obstet Gynecol (2013) 1.62
Systematic discovery of ectopic pregnancy serum biomarkers using 3-D protein profiling coupled with label-free quantitation. J Proteome Res (2011) 1.14
Population-based ectopic pregnancy trends, 1993-2007. Am J Prev Med (2011) 1.00
Cost-effectiveness analysis of levonorgestrel-releasing intrauterine system (LNG-IUS) 13.5 mg in contraception. Contraception (2014) 0.90
Achieving cost-neutrality with long-acting reversible contraceptive methods. Contraception (2014) 0.90
Early pregnancy failure: beware of the pitfalls of modern management. Fertil Steril (2012) 0.89
Improving automated case finding for ectopic pregnancy using a classification algorithm. Hum Reprod (2011) 0.86
How and when human chorionic gonadotropin curves in women with an ectopic pregnancy mimic other outcomes: differences by race and ethnicity. Fertil Steril (2012) 0.86
Ectopic pregnancy rates and racial disparities in the Medicaid population, 2004-2008. Fertil Steril (2014) 0.84
Biomarkers for ectopic pregnancy and pregnancy of unknown location. Fertil Steril (2013) 0.84
Trend of ectopic pregnancy and its main determinants in Hamadan province, Iran (2000-2010). BMC Res Notes (2014) 0.82
The value of ratio of hCG, progesterone in local blood of pregnancy location versus venous blood in the diagnosis of ectopic pregnancy. Int J Clin Exp Med (2015) 0.81
Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception. J Fam Plann Reprod Health Care (2014) 0.79
Ectopic pregnancy: still cause for concern. Obstet Gynecol (2010) 0.79
Validation of a clinical risk scoring system, based solely on clinical presentation, for the management of pregnancy of unknown location. Fertil Steril (2012) 0.78
Tubal ectopic pregnancy. BMJ Clin Evid (2012) 0.77
Trends in ectopic pregnancy, hydatidiform mole and miscarriage in the largest obstetrics and gynaecology hospital in China from 2003 to 2013. Reprod Health (2016) 0.75
Ectopic pregnancy prediction in women with a pregnancy of unknown location: data beyond 48 h are necessary. Hum Reprod (2013) 0.75
Placental mRNA in maternal plasma as a predictor of ectopic pregnancy. Int J Gynaecol Obstet (2012) 0.75
Is a Self-Assessed Questionnaire Useful for the Diagnosis of Ectopic Pregnancy in Hospitalized Patients? PLoS One (2016) 0.75
Evaluation of Plasma Creatine Phosphokinase (CPK) Level Following a Single Injection of Methotrexate as a Predicator of Treatment Success in Ectopic Pregnancy. J Family Reprod Health (2013) 0.75
Following declining human chorionic gonadotropin values in pregnancies of unknown location: when is it safe to stop? Fertil Steril (2015) 0.75
The Role of Plasma Creatine Phosphokinase (CPK) Level in Prediction of Response to Methotrexate for Ectopic Pregnancy. J Family Reprod Health (2016) 0.75
Ectopic pregnancy among American Indian and Alaska Native women, 2002-2009. Matern Child Health J (2015) 0.75
Predicting first trimester pregnancy outcome: derivation of a multiple marker test. Fertil Steril (2016) 0.75
ACUTE PELVIC PAIN IN THE ADOLESCENT: A CASE REPORT. Clin Pediatr Emerg Med (2015) 0.75
Diagnostic value of the plasmatic ADM level for early ectopic pregnancy. Int J Clin Exp Pathol (2015) 0.75
Disparities in the management of ectopic pregnancy. Am J Obstet Gynecol (2017) 0.75
Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65
The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health (2004) 3.95
Heterosexual anal sex activity in the year after an STD clinic visit. Sex Transm Dis (2008) 2.59
The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis (2013) 2.39
Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003. Sex Transm Dis (2005) 2.08
Utilization of health services in physician offices and outpatient clinics by adolescents and young women in the United States: implications for improving access to reproductive health services. J Adolesc Health (2009) 1.76
Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004. Clin Infect Dis (2005) 1.64
The psychosocial impact of testing individuals with no history of genital herpes for herpes simplex virus type 2. Sex Transm Dis (2004) 1.61
Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis (2003) 1.56
HIV testing frequency among men who have sex with men attending sexually transmitted disease clinics: implications for HIV prevention and surveillance. J Acquir Immune Defic Syndr (2009) 1.55
Use of cervical cancer screening among insured women: the extent of missed opportunities. Health Policy (2004) 1.51
Household effects of school closure during pandemic (H1N1) 2009, Pennsylvania, USA. Emerg Infect Dis (2010) 1.49
Field-delivered therapy increases treatment for chlamydia and gonorrhea. Am J Public Health (2003) 1.41
Access to care issues for African American communities: implications for STD disparities. Sex Transm Dis (2008) 1.39
HIV partner notification outcomes for HIV-infected patients by duration of infection, San Francisco, 2004 to 2006. J Acquir Immune Defic Syndr (2007) 1.27
STD screening of HIV-infected MSM in HIV clinics. Sex Transm Dis (2010) 1.23
Risk factors for rectal gonococcal infection amidst resurgence in HIV transmission. Sex Transm Dis (2003) 1.21
Increased risk of HIV and sexually transmitted disease transmission among gay or bisexual men who use Viagra, San Francisco 2000-2001. AIDS (2002) 1.20
Missed opportunities for chlamydia screening of young women in the United States. Obstet Gynecol (2008) 1.12
Detection of acute HIV infections. N Engl J Med (2005) 1.10
Monitoring HIV testing at visits to emergency departments in the United States: very-low rate of HIV testing. J Acquir Immune Defic Syndr (2013) 1.09
The public health response to epidemic syphilis, San Francisco, 1999-2004. Sex Transm Dis (2005) 1.08
Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005-2006. Sex Transm Dis (2008) 1.06
Low rates of hepatitis screening and vaccination of HIV-infected MSM in HIV clinics. Sex Transm Dis (2012) 1.05
Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect (2006) 1.05
Chlamydia trachomatis and Neisseria gonorrhoeae prevalence and coinfection in adolescents entering selected US juvenile detention centers, 1997-2002. Sex Transm Dis (2005) 1.04
Uptake of regular chlamydia testing by U.S. women: a longitudinal study. Am J Prev Med (2010) 1.04
Social marketing campaign significantly associated with increases in syphilis testing among gay and bisexual men in San Francisco. Sex Transm Dis (2005) 1.03
2009 cervical cytology guidelines and chlamydia testing among sexually active young women. Obstet Gynecol (2010) 1.02
Risk factors for repeat syphilis in men who have sex with men, San Francisco. Sex Transm Dis (2009) 1.02
Low rates of both asymptomatic chlamydia screening and diagnostic testing of women in US outpatient clinics. Obstet Gynecol (2008) 1.01
A brief review of the estimated economic burden of sexually transmitted diseases in the United States: inflation-adjusted updates of previously published cost studies. Sex Transm Dis (2011) 1.01
The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women. Sex Transm Dis (2008) 1.01
The cost-effectiveness of screening men who have sex with men for rectal chlamydial and gonococcal infection to prevent HIV Infection. Sex Transm Dis (2013) 1.00
Suboptimal adherence to repeat testing recommendations for men and women with positive Chlamydia tests in the United States, 2008-2010. Clin Infect Dis (2012) 0.99
High prevalence of gonococcal and chlamydial infection in men who have sex with men with newly diagnosed HIV infection: an opportunity for same-day presumptive treatment. J Acquir Immune Defic Syndr (2008) 0.99
Is jail screening associated with a decrease in Chlamydia positivity among females seeking health services at community clinics?-San francisco, 1997-2004. Sex Transm Dis (2009) 0.99
Declining rates in male circumcision amidst increasing evidence of its public health benefit. PLoS One (2007) 0.99
Cost-effectiveness of integrated routine offering of prenatal HIV and syphilis screening in China. Sex Transm Dis (2014) 0.99
Estimates of the direct cost per case and overall burden of trichomoniasis for the employer-sponsored privately insured women population in the United States, 2001 to 2005. Sex Transm Dis (2009) 0.99
Stop the sores: the making and evaluation of a successful social marketing campaign. Health Promot Pract (2008) 0.99
Rate and predictors of repeat Chlamydia trachomatis infection among men. Sex Transm Dis (2008) 0.98
Predictive value of clinical diagnostic codes for the CDC case definition of pelvic inflammatory disease (PID): implications for surveillance. Sex Transm Dis (2003) 0.97
The use and performance of oral-throat rinses to detect pharyngeal Neisseria gonorrhoeae and Chlamydia trachomatis infections. Diagn Microbiol Infect Dis (2007) 0.96
Results of a program to test women for rectal chlamydia and gonorrhea. Obstet Gynecol (2010) 0.95
Sex and age correlates of Chlamydia prevalence in adolescents and adults entering correctional facilities, 2005: implications for screening policy. Sex Transm Dis (2009) 0.93
Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis (2010) 0.92
Chlamydia screening in a Health Plan before and after a national performance measure introduction. Obstet Gynecol (2005) 0.91
Chlamydia trachomatis positivity rates among men tested in selected venues in the United States: a review of the recent literature. Sex Transm Dis (2008) 0.89
Incidence and prevalence of herpes simplex virus type 2 infection in persons seeking repeat HIV counseling and testing. Sex Transm Dis (2003) 0.89
Chlamydia screening and pelvic inflammatory disease: Insights from exploratory time-series analyses. Am J Prev Med (2010) 0.88
Risk factors for gonorrhea among heterosexuals--San Francisco, 2006. Sex Transm Dis (2009) 0.88
The decline in clinical sequelae of genital Chlamydia trachomatis infection supports current control strategies. J Infect Dis (2006) 0.87
Insights into the timing of repeated testing after treatment for Chlamydia trachomatis: data and modelling study. Sex Transm Infect (2012) 0.87
Differences in access to health care services among adults in rural America by rural classification categories and age. Aust J Rural Health (2003) 0.87
Self-reported Chlamydia testing rates of sexually active women aged 15-25 years in the United States, 2006-2008. Sex Transm Dis (2012) 0.86
Serologic herpes testing in the real world: validation of new type-specific serologic herpes simplex virus tests in a public health laboratory. Sex Transm Dis (2002) 0.86
Methamphetamine use and sexual activity among HIV-infected patients in care--San Francisco, 2004. AIDS Patient Care STDS (2006) 0.86
Provision of sexual health services to adolescent enrollees in Medicaid managed care. Am J Public Health (2002) 0.85
Investigating the potential public health benefit of jail-based screening and treatment programs for chlamydia. Am J Epidemiol (2013) 0.85
Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis. Am J Public Health (2009) 0.85
The association between racial disparity in income and reported sexually transmitted infections. Am J Public Health (2013) 0.82
Epidemiologic research using administrative databases: garbage in, garbage out. Obstet Gynecol (2011) 0.82
Chlamydia testing patterns for commercially insured women, 2008. Am J Prev Med (2012) 0.81
Stay in school? Results of a sexually transmitted diseases screening program in San Francisco high schools-2007. Sex Transm Dis (2008) 0.81
Screening for human immunodeficiency virus and other sexually transmitted diseases among U.S. women with prenatal care. Obstet Gynecol (2015) 0.80
Use of NAATs for STD diagnosis of GC and CT in non-FDA -cleared anatomic specimens. MLO Med Lab Obs (2006) 0.80
Chlamydia screening of young sexually active, Medicaid-insured women by race and ethnicity, 2002-2005. Sex Transm Dis (2009) 0.80
Chlamydia screening among females aged 15-21 years--multiple data sources, United States, 1999-2010. MMWR Surveill Summ (2014) 0.79
Optimising sexually transmitted infection screening in correctional facilities: San Francisco, 2003-2005. Sex Transm Infect (2007) 0.79
Racial and ethnic disparities in prenatal syphilis screening among women with Medicaid-covered deliveries in Florida. Matern Child Health J (2007) 0.78
Disparities in sexually transmitted disease rates across the "eight Americas". Sex Transm Dis (2012) 0.78
Higher yet suboptimal chlamydia testing rates at community health centers and outpatient clinics compared with physician offices. Am J Public Health (2012) 0.78
Prenatal syphilis screening rates measured using medicaid claims and electronic medical records. Sex Transm Dis (2008) 0.78
Demographic and Health Services Characteristics Associated With Testing for Sexually Transmitted Infections Among a Commercially Insured Population of HIV-Positive Patients. J Acquir Immune Defic Syndr (2015) 0.78
Healthy Penis: San Francisco's social marketing campaign to increase syphilis testing among gay and bisexual men. PLoS Med (2006) 0.78
Estimating the direct outpatient medical cost per episode of primary and secondary syphilis in the United States: insured population perspective, 2003-2007. Sex Transm Dis (2011) 0.77
Azithromycin versus penicillin for early syphilis. N Engl J Med (2006) 0.76
Increase in Urgent Care Center Visits for Sexually Transmitted Infections, United States, 2010-2014. Emerg Infect Dis (2017) 0.75
Racial Differences in Receipt of Chlamydia Testing Among Medicaid-Insured Women in 2013. Sex Transm Dis (2016) 0.75
Sexually transmitted disease care in managed care organizations. Infect Dis Clin North Am (2005) 0.75
Diagnostic methodologies for chlamydia screening in females aged 15 to 25 years from private insurance claims data in the United States, 2001 to 2005. Sex Transm Dis (2009) 0.75
The Significant Impact of Different Insurance Enrollment Criteria on the HEDIS Chlamydia Screening Measure for Young Women Enrolled in Medicaid and Commercial Insurance Plans. Sex Transm Dis (2015) 0.75
The Program Cost of a Brief Video Intervention Shown in Sexually Transmitted Disease Clinic Waiting Rooms. Sex Transm Dis (2016) 0.75
HIV and sexually transmitted diseases. Latest views on synergy, treatment, and screening. Postgrad Med (2004) 0.75
Explaining racial differences in prenatal care initiation and syphilis screening among Medicaid-covered pregnant women. J Health Care Poor Underserved (2009) 0.75
Patterns of single and multiple claims of epididymitis among young privately-insured males in the United States, 2001 to 2004. Sex Transm Dis (2009) 0.75
Provider Adherence to Syphilis Testing Recommendations for Women Delivering a Stillbirth. Sex Transm Dis (2017) 0.75
Patterns in prenatal syphilis screening among Florida Medicaid enrollees. Sex Transm Dis (2007) 0.75
Suboptimal Prenatal Syphilis Testing Among Commercially Insured Women in the United States, 2013. Sex Transm Dis (2017) 0.75